Vaccine against MPOX (Monkeypox)

Primary vaccination (individuals not previously vaccinated against smallpox):

A first dose of 0.5 mL should be administered at a specified date. A second dose of 0.5 mL should be administered no less than 28 days after the first dose.

Booster vaccination

(individuals previously vaccinated against smallpox): Inadequate data exist to determine the appropriate time for booster doses. If a booster dose is considered necessary, a single dose of 0.5 mL should be administered.I

Immunocompromised patients (e.g., patients with HIV infection, patients on immunosuppressive therapy)

he have already been vaccinated against smallpox should receive two booster doses. The second booster vaccination should be administered no less than 28 days after the first dose.

The vaccine consists of modified live Ankara vaccine virus

The vaccine is administered by subcutaneous injection, preferably in the arm (deltoid)

Contraindications Hypersensitivity to the active ingredient or any of the excipients ( trometamol, sodium chloride, water for injection preparations ) or to trace residues ( chicken protein, benzonase and gentamicin ). The most common side effects of Imvanex ( which may affect more than 1 in 10 people ) are headache, nausea, myalgia ( muscle pain ), fatigue, and injection site reactions ( pain, redness, swelling, induration, and itching sensation ).